Position in SANA
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$4,599,582
+$803,938 QoQ
Shares Held
1,317,932
0.0% QoQ
Ownership
0.440%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#20
of 211 holders
Holding Since
Mar 2021
22 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in SANA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Woodline Partners LP holds $4,400,572,274 across 197 Biotechnology names. SANA ranks #140 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | RVMD |
Revolution Medicines, Inc.
|
2,002,863 | $375,096,182 | |
| 2 | PTGX |
Protagonist Therapeutics, Inc
|
1,414,173 | $173,349,326 | |
| 3 | TNGX |
Tango Therapeutics, Inc.
|
4,000,567 | $125,057,724 | |
| 4 | BHVN |
Biohaven Ltd.
|
7,660,280 | $113,984,966 | |
| 5 | COGT |
Cogent Biosciences, Inc.
|
2,603,162 | $100,742,369 | |
| 6 | CYTK |
Cytokinetics Inc
|
1,100,708 | $93,769,314 | |
| 7 | RCUS |
Arcus Biosciences, Inc.
|
3,007,798 | $92,730,412 | |
| 8 | ROIV |
Roivant Sciences Ltd.
|
2,500,673 | $88,498,817 |
All Filings in SANA
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,599,582 | 1,317,932 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $3,795,644 | 1,317,932 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $5,362,798 | 1,317,641 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $4,892,737 | 1,378,236 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $2,132,736 | 781,222 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $1,311,502 | 780,656 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $1,124,929 | 690,141 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $2,861,335 | 687,821 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $3,735,699 | 684,194 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $8,990,500 | 899,050 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $2,791,511 | 684,194 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $1,367,379 | 353,328 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $2,086,000 | 350,000 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $2,289,000 | 700,000 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $2,461,900 | 623,266 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $7,301,496 | 1,216,916 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $8,508,388 | 1,323,233 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $12,819,024 | 1,551,940 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $7,472,288 | 482,706 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $9,455,404 | 419,867 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $8,077,271 | 410,848 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $13,454,739 | 401,994 | Shares | Sole | 2021-05-17 | |
| No filing history on record for this holder in this stock. | ||||||